Correction: Corrigendum: Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India

Nat. Biotechnol. 28, 671–678 (2010); published online 8 July 2010; corrected after print 7 February 2012

In the version of this article initially published, on p. 671, column 2, the authors state: “Merck has donated three million doses of Gardasil to the Program for Appropriate Technology in Health (PATH) for demonstration trials¹⁴. Its Gardasil Access Program aims to extend this support to eight LMCs¹⁵.” It should have read: “Merck donated about 130,000 doses to PATH for demonstration studies in India, Peru and Vietnam¹⁴. Through the Gardasil Access Program, Merck aims to extend its support to LMCs and has pledged to make 3 million doses of vaccine available to eligible countries¹⁵.” In addition, reference 14 should have been Tsu, V. PATH/Seattle, personal communication (2011), rather than Harner-Jay et al. J. Pharm. Sci. (2008).